Global Biosimilar Monoclonal Antibody Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biosimilar Monoclonal Antibody market size was valued at USD 4639.7 million in 2023 and is forecast to a readjusted size of USD 5805.5 million by 2030 with a CAGR of 3.3% during review period.
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.
Global Biosimilar Monoclonal Antibodies key players include Celltrion, 3SBIO, Pfizer (Hospira), Novartis (Sandoz), etc. Global top four manufacturers hold a share nearly 85%.
Europe is the largest market, with a share about 40%, followed by China, and United States, both have a share about 50 percent.
In terms of product, Infliximab is the largest segment, with a share nearly 40%. And in terms of application, the largest application is Autoimmune Disease, followed by Oncology, etc.
The Global Info Research report includes an overview of the development of the Biosimilar Monoclonal Antibody industry chain, the market status of Chronic & Autoimmune Diseases (Limited Dilution Method, Micromanipulation), Oncology (Limited Dilution Method, Micromanipulation), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar Monoclonal Antibody.
Regionally, the report analyzes the Biosimilar Monoclonal Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar Monoclonal Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar Monoclonal Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar Monoclonal Antibody industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Limited Dilution Method, Micromanipulation).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar Monoclonal Antibody market.
Regional Analysis: The report involves examining the Biosimilar Monoclonal Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar Monoclonal Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar Monoclonal Antibody:
Company Analysis: Report covers individual Biosimilar Monoclonal Antibody players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar Monoclonal Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chronic & Autoimmune Diseases, Oncology).
Technology Analysis: Report covers specific technologies relevant to Biosimilar Monoclonal Antibody. It assesses the current state, advancements, and potential future developments in Biosimilar Monoclonal Antibody areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar Monoclonal Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar Monoclonal Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Biosimilar Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar Monoclonal Antibody, with revenue, gross margin and global market share of Biosimilar Monoclonal Antibody from 2019 to 2024.
Chapter 3, the Biosimilar Monoclonal Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biosimilar Monoclonal Antibody market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar Monoclonal Antibody.
Chapter 13, to describe Biosimilar Monoclonal Antibody research findings and conclusion.
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.
Global Biosimilar Monoclonal Antibodies key players include Celltrion, 3SBIO, Pfizer (Hospira), Novartis (Sandoz), etc. Global top four manufacturers hold a share nearly 85%.
Europe is the largest market, with a share about 40%, followed by China, and United States, both have a share about 50 percent.
In terms of product, Infliximab is the largest segment, with a share nearly 40%. And in terms of application, the largest application is Autoimmune Disease, followed by Oncology, etc.
The Global Info Research report includes an overview of the development of the Biosimilar Monoclonal Antibody industry chain, the market status of Chronic & Autoimmune Diseases (Limited Dilution Method, Micromanipulation), Oncology (Limited Dilution Method, Micromanipulation), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar Monoclonal Antibody.
Regionally, the report analyzes the Biosimilar Monoclonal Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar Monoclonal Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar Monoclonal Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar Monoclonal Antibody industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Limited Dilution Method, Micromanipulation).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar Monoclonal Antibody market.
Regional Analysis: The report involves examining the Biosimilar Monoclonal Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar Monoclonal Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar Monoclonal Antibody:
Company Analysis: Report covers individual Biosimilar Monoclonal Antibody players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar Monoclonal Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chronic & Autoimmune Diseases, Oncology).
Technology Analysis: Report covers specific technologies relevant to Biosimilar Monoclonal Antibody. It assesses the current state, advancements, and potential future developments in Biosimilar Monoclonal Antibody areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar Monoclonal Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar Monoclonal Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Limited Dilution Method
- Micromanipulation
- Soft Agar Plate Method
- Others
- Chronic & Autoimmune Diseases
- Oncology
- Others
- Biocon
- Accord Healthcare
- AET Biotech
- Amgen
- Celltrion
- Reddy's Laboratories
- Hospira
- 3SBio
- Allergan
- Alvartis
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biosimilar Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar Monoclonal Antibody, with revenue, gross margin and global market share of Biosimilar Monoclonal Antibody from 2019 to 2024.
Chapter 3, the Biosimilar Monoclonal Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biosimilar Monoclonal Antibody market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar Monoclonal Antibody.
Chapter 13, to describe Biosimilar Monoclonal Antibody research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar Monoclonal Antibody by Type
1.3.1 Overview: Global Biosimilar Monoclonal Antibody Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Type in 2023
1.3.3 Limited Dilution Method
1.3.4 Micromanipulation
1.3.5 Soft Agar Plate Method
1.3.6 Others
1.4 Global Biosimilar Monoclonal Antibody Market by Application
1.4.1 Overview: Global Biosimilar Monoclonal Antibody Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Chronic & Autoimmune Diseases
1.4.3 Oncology
1.4.4 Others
1.5 Global Biosimilar Monoclonal Antibody Market Size & Forecast
1.6 Global Biosimilar Monoclonal Antibody Market Size and Forecast by Region
1.6.1 Global Biosimilar Monoclonal Antibody Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biosimilar Monoclonal Antibody Market Size by Region, (2019-2030)
1.6.3 North America Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.4 Europe Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.6 South America Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Biocon
2.1.1 Biocon Details
2.1.2 Biocon Major Business
2.1.3 Biocon Biosimilar Monoclonal Antibody Product and Solutions
2.1.4 Biocon Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Biocon Recent Developments and Future Plans
2.2 Accord Healthcare
2.2.1 Accord Healthcare Details
2.2.2 Accord Healthcare Major Business
2.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Product and Solutions
2.2.4 Accord Healthcare Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Accord Healthcare Recent Developments and Future Plans
2.3 AET Biotech
2.3.1 AET Biotech Details
2.3.2 AET Biotech Major Business
2.3.3 AET Biotech Biosimilar Monoclonal Antibody Product and Solutions
2.3.4 AET Biotech Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AET Biotech Recent Developments and Future Plans
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Biosimilar Monoclonal Antibody Product and Solutions
2.4.4 Amgen Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Amgen Recent Developments and Future Plans
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Biosimilar Monoclonal Antibody Product and Solutions
2.5.4 Celltrion Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Celltrion Recent Developments and Future Plans
2.6 Reddy's Laboratories
2.6.1 Reddy's Laboratories Details
2.6.2 Reddy's Laboratories Major Business
2.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Product and Solutions
2.6.4 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Reddy's Laboratories Recent Developments and Future Plans
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business
2.7.3 Hospira Biosimilar Monoclonal Antibody Product and Solutions
2.7.4 Hospira Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hospira Recent Developments and Future Plans
2.8 3SBio
2.8.1 3SBio Details
2.8.2 3SBio Major Business
2.8.3 3SBio Biosimilar Monoclonal Antibody Product and Solutions
2.8.4 3SBio Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 3SBio Recent Developments and Future Plans
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Biosimilar Monoclonal Antibody Product and Solutions
2.9.4 Allergan Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Allergan Recent Developments and Future Plans
2.10 Alvartis
2.10.1 Alvartis Details
2.10.2 Alvartis Major Business
2.10.3 Alvartis Biosimilar Monoclonal Antibody Product and Solutions
2.10.4 Alvartis Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Alvartis Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilar Monoclonal Antibody Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biosimilar Monoclonal Antibody by Company Revenue
3.2.2 Top 3 Biosimilar Monoclonal Antibody Players Market Share in 2023
3.2.3 Top 6 Biosimilar Monoclonal Antibody Players Market Share in 2023
3.3 Biosimilar Monoclonal Antibody Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Monoclonal Antibody Market: Region Footprint
3.3.2 Biosimilar Monoclonal Antibody Market: Company Product Type Footprint
3.3.3 Biosimilar Monoclonal Antibody Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilar Monoclonal Antibody Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biosimilar Monoclonal Antibody Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2024)
5.2 Global Biosimilar Monoclonal Antibody Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
6.2 North America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
6.3 North America Biosimilar Monoclonal Antibody Market Size by Country
6.3.1 North America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
6.3.2 United States Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
6.3.3 Canada Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
6.3.4 Mexico Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
7.2 Europe Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Country
7.3.1 Europe Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
7.3.2 Germany Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.3 France Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.5 Russia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.6 Italy Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region
8.3.1 Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Region (2019-2030)
8.3.2 China Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.3 Japan Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.4 South Korea Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.5 India Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.7 Australia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
9.2 South America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
9.3 South America Biosimilar Monoclonal Antibody Market Size by Country
9.3.1 South America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
9.3.2 Brazil Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
9.3.3 Argentina Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country
10.3.1 Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
10.3.2 Turkey Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
10.3.4 UAE Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biosimilar Monoclonal Antibody Market Drivers
11.2 Biosimilar Monoclonal Antibody Market Restraints
11.3 Biosimilar Monoclonal Antibody Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilar Monoclonal Antibody Industry Chain
12.2 Biosimilar Monoclonal Antibody Upstream Analysis
12.3 Biosimilar Monoclonal Antibody Midstream Analysis
12.4 Biosimilar Monoclonal Antibody Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar Monoclonal Antibody by Type
1.3.1 Overview: Global Biosimilar Monoclonal Antibody Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Type in 2023
1.3.3 Limited Dilution Method
1.3.4 Micromanipulation
1.3.5 Soft Agar Plate Method
1.3.6 Others
1.4 Global Biosimilar Monoclonal Antibody Market by Application
1.4.1 Overview: Global Biosimilar Monoclonal Antibody Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Chronic & Autoimmune Diseases
1.4.3 Oncology
1.4.4 Others
1.5 Global Biosimilar Monoclonal Antibody Market Size & Forecast
1.6 Global Biosimilar Monoclonal Antibody Market Size and Forecast by Region
1.6.1 Global Biosimilar Monoclonal Antibody Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biosimilar Monoclonal Antibody Market Size by Region, (2019-2030)
1.6.3 North America Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.4 Europe Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.6 South America Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biosimilar Monoclonal Antibody Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Biocon
2.1.1 Biocon Details
2.1.2 Biocon Major Business
2.1.3 Biocon Biosimilar Monoclonal Antibody Product and Solutions
2.1.4 Biocon Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Biocon Recent Developments and Future Plans
2.2 Accord Healthcare
2.2.1 Accord Healthcare Details
2.2.2 Accord Healthcare Major Business
2.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Product and Solutions
2.2.4 Accord Healthcare Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Accord Healthcare Recent Developments and Future Plans
2.3 AET Biotech
2.3.1 AET Biotech Details
2.3.2 AET Biotech Major Business
2.3.3 AET Biotech Biosimilar Monoclonal Antibody Product and Solutions
2.3.4 AET Biotech Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AET Biotech Recent Developments and Future Plans
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Biosimilar Monoclonal Antibody Product and Solutions
2.4.4 Amgen Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Amgen Recent Developments and Future Plans
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Biosimilar Monoclonal Antibody Product and Solutions
2.5.4 Celltrion Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Celltrion Recent Developments and Future Plans
2.6 Reddy's Laboratories
2.6.1 Reddy's Laboratories Details
2.6.2 Reddy's Laboratories Major Business
2.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Product and Solutions
2.6.4 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Reddy's Laboratories Recent Developments and Future Plans
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business
2.7.3 Hospira Biosimilar Monoclonal Antibody Product and Solutions
2.7.4 Hospira Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hospira Recent Developments and Future Plans
2.8 3SBio
2.8.1 3SBio Details
2.8.2 3SBio Major Business
2.8.3 3SBio Biosimilar Monoclonal Antibody Product and Solutions
2.8.4 3SBio Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 3SBio Recent Developments and Future Plans
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Biosimilar Monoclonal Antibody Product and Solutions
2.9.4 Allergan Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Allergan Recent Developments and Future Plans
2.10 Alvartis
2.10.1 Alvartis Details
2.10.2 Alvartis Major Business
2.10.3 Alvartis Biosimilar Monoclonal Antibody Product and Solutions
2.10.4 Alvartis Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Alvartis Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilar Monoclonal Antibody Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biosimilar Monoclonal Antibody by Company Revenue
3.2.2 Top 3 Biosimilar Monoclonal Antibody Players Market Share in 2023
3.2.3 Top 6 Biosimilar Monoclonal Antibody Players Market Share in 2023
3.3 Biosimilar Monoclonal Antibody Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Monoclonal Antibody Market: Region Footprint
3.3.2 Biosimilar Monoclonal Antibody Market: Company Product Type Footprint
3.3.3 Biosimilar Monoclonal Antibody Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilar Monoclonal Antibody Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biosimilar Monoclonal Antibody Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2024)
5.2 Global Biosimilar Monoclonal Antibody Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
6.2 North America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
6.3 North America Biosimilar Monoclonal Antibody Market Size by Country
6.3.1 North America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
6.3.2 United States Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
6.3.3 Canada Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
6.3.4 Mexico Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
7.2 Europe Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Country
7.3.1 Europe Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
7.3.2 Germany Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.3 France Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.5 Russia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
7.3.6 Italy Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region
8.3.1 Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Region (2019-2030)
8.3.2 China Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.3 Japan Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.4 South Korea Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.5 India Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
8.3.7 Australia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
9.2 South America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
9.3 South America Biosimilar Monoclonal Antibody Market Size by Country
9.3.1 South America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
9.3.2 Brazil Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
9.3.3 Argentina Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country
10.3.1 Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2030)
10.3.2 Turkey Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
10.3.4 UAE Biosimilar Monoclonal Antibody Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biosimilar Monoclonal Antibody Market Drivers
11.2 Biosimilar Monoclonal Antibody Market Restraints
11.3 Biosimilar Monoclonal Antibody Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilar Monoclonal Antibody Industry Chain
12.2 Biosimilar Monoclonal Antibody Upstream Analysis
12.3 Biosimilar Monoclonal Antibody Midstream Analysis
12.4 Biosimilar Monoclonal Antibody Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilar Monoclonal Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar Monoclonal Antibody Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biosimilar Monoclonal Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biosimilar Monoclonal Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Biocon Company Information, Head Office, and Major Competitors
Table 6. Biocon Major Business
Table 7. Biocon Biosimilar Monoclonal Antibody Product and Solutions
Table 8. Biocon Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Biocon Recent Developments and Future Plans
Table 10. Accord Healthcare Company Information, Head Office, and Major Competitors
Table 11. Accord Healthcare Major Business
Table 12. Accord Healthcare Biosimilar Monoclonal Antibody Product and Solutions
Table 13. Accord Healthcare Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Accord Healthcare Recent Developments and Future Plans
Table 15. AET Biotech Company Information, Head Office, and Major Competitors
Table 16. AET Biotech Major Business
Table 17. AET Biotech Biosimilar Monoclonal Antibody Product and Solutions
Table 18. AET Biotech Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. AET Biotech Recent Developments and Future Plans
Table 20. Amgen Company Information, Head Office, and Major Competitors
Table 21. Amgen Major Business
Table 22. Amgen Biosimilar Monoclonal Antibody Product and Solutions
Table 23. Amgen Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Amgen Recent Developments and Future Plans
Table 25. Celltrion Company Information, Head Office, and Major Competitors
Table 26. Celltrion Major Business
Table 27. Celltrion Biosimilar Monoclonal Antibody Product and Solutions
Table 28. Celltrion Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Celltrion Recent Developments and Future Plans
Table 30. Reddy's Laboratories Company Information, Head Office, and Major Competitors
Table 31. Reddy's Laboratories Major Business
Table 32. Reddy's Laboratories Biosimilar Monoclonal Antibody Product and Solutions
Table 33. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Reddy's Laboratories Recent Developments and Future Plans
Table 35. Hospira Company Information, Head Office, and Major Competitors
Table 36. Hospira Major Business
Table 37. Hospira Biosimilar Monoclonal Antibody Product and Solutions
Table 38. Hospira Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hospira Recent Developments and Future Plans
Table 40. 3SBio Company Information, Head Office, and Major Competitors
Table 41. 3SBio Major Business
Table 42. 3SBio Biosimilar Monoclonal Antibody Product and Solutions
Table 43. 3SBio Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. 3SBio Recent Developments and Future Plans
Table 45. Allergan Company Information, Head Office, and Major Competitors
Table 46. Allergan Major Business
Table 47. Allergan Biosimilar Monoclonal Antibody Product and Solutions
Table 48. Allergan Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Allergan Recent Developments and Future Plans
Table 50. Alvartis Company Information, Head Office, and Major Competitors
Table 51. Alvartis Major Business
Table 52. Alvartis Biosimilar Monoclonal Antibody Product and Solutions
Table 53. Alvartis Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Alvartis Recent Developments and Future Plans
Table 55. Global Biosimilar Monoclonal Antibody Revenue (USD Million) by Players (2019-2024)
Table 56. Global Biosimilar Monoclonal Antibody Revenue Share by Players (2019-2024)
Table 57. Breakdown of Biosimilar Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Biosimilar Monoclonal Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Biosimilar Monoclonal Antibody Players
Table 60. Biosimilar Monoclonal Antibody Market: Company Product Type Footprint
Table 61. Biosimilar Monoclonal Antibody Market: Company Product Application Footprint
Table 62. Biosimilar Monoclonal Antibody New Market Entrants and Barriers to Market Entry
Table 63. Biosimilar Monoclonal Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Biosimilar Monoclonal Antibody Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Biosimilar Monoclonal Antibody Consumption Value Share by Type (2019-2024)
Table 66. Global Biosimilar Monoclonal Antibody Consumption Value Forecast by Type (2025-2030)
Table 67. Global Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024)
Table 68. Global Biosimilar Monoclonal Antibody Consumption Value Forecast by Application (2025-2030)
Table 69. North America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Biosimilar Monoclonal Antibody Raw Material
Table 100. Key Suppliers of Biosimilar Monoclonal Antibody Raw Materials
Table 1. Global Biosimilar Monoclonal Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar Monoclonal Antibody Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biosimilar Monoclonal Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biosimilar Monoclonal Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Biocon Company Information, Head Office, and Major Competitors
Table 6. Biocon Major Business
Table 7. Biocon Biosimilar Monoclonal Antibody Product and Solutions
Table 8. Biocon Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Biocon Recent Developments and Future Plans
Table 10. Accord Healthcare Company Information, Head Office, and Major Competitors
Table 11. Accord Healthcare Major Business
Table 12. Accord Healthcare Biosimilar Monoclonal Antibody Product and Solutions
Table 13. Accord Healthcare Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Accord Healthcare Recent Developments and Future Plans
Table 15. AET Biotech Company Information, Head Office, and Major Competitors
Table 16. AET Biotech Major Business
Table 17. AET Biotech Biosimilar Monoclonal Antibody Product and Solutions
Table 18. AET Biotech Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. AET Biotech Recent Developments and Future Plans
Table 20. Amgen Company Information, Head Office, and Major Competitors
Table 21. Amgen Major Business
Table 22. Amgen Biosimilar Monoclonal Antibody Product and Solutions
Table 23. Amgen Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Amgen Recent Developments and Future Plans
Table 25. Celltrion Company Information, Head Office, and Major Competitors
Table 26. Celltrion Major Business
Table 27. Celltrion Biosimilar Monoclonal Antibody Product and Solutions
Table 28. Celltrion Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Celltrion Recent Developments and Future Plans
Table 30. Reddy's Laboratories Company Information, Head Office, and Major Competitors
Table 31. Reddy's Laboratories Major Business
Table 32. Reddy's Laboratories Biosimilar Monoclonal Antibody Product and Solutions
Table 33. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Reddy's Laboratories Recent Developments and Future Plans
Table 35. Hospira Company Information, Head Office, and Major Competitors
Table 36. Hospira Major Business
Table 37. Hospira Biosimilar Monoclonal Antibody Product and Solutions
Table 38. Hospira Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hospira Recent Developments and Future Plans
Table 40. 3SBio Company Information, Head Office, and Major Competitors
Table 41. 3SBio Major Business
Table 42. 3SBio Biosimilar Monoclonal Antibody Product and Solutions
Table 43. 3SBio Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. 3SBio Recent Developments and Future Plans
Table 45. Allergan Company Information, Head Office, and Major Competitors
Table 46. Allergan Major Business
Table 47. Allergan Biosimilar Monoclonal Antibody Product and Solutions
Table 48. Allergan Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Allergan Recent Developments and Future Plans
Table 50. Alvartis Company Information, Head Office, and Major Competitors
Table 51. Alvartis Major Business
Table 52. Alvartis Biosimilar Monoclonal Antibody Product and Solutions
Table 53. Alvartis Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Alvartis Recent Developments and Future Plans
Table 55. Global Biosimilar Monoclonal Antibody Revenue (USD Million) by Players (2019-2024)
Table 56. Global Biosimilar Monoclonal Antibody Revenue Share by Players (2019-2024)
Table 57. Breakdown of Biosimilar Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Biosimilar Monoclonal Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Biosimilar Monoclonal Antibody Players
Table 60. Biosimilar Monoclonal Antibody Market: Company Product Type Footprint
Table 61. Biosimilar Monoclonal Antibody Market: Company Product Application Footprint
Table 62. Biosimilar Monoclonal Antibody New Market Entrants and Barriers to Market Entry
Table 63. Biosimilar Monoclonal Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Biosimilar Monoclonal Antibody Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Biosimilar Monoclonal Antibody Consumption Value Share by Type (2019-2024)
Table 66. Global Biosimilar Monoclonal Antibody Consumption Value Forecast by Type (2025-2030)
Table 67. Global Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024)
Table 68. Global Biosimilar Monoclonal Antibody Consumption Value Forecast by Application (2025-2030)
Table 69. North America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Biosimilar Monoclonal Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Biosimilar Monoclonal Antibody Raw Material
Table 100. Key Suppliers of Biosimilar Monoclonal Antibody Raw Materials
LIST OF FIGURES
Figure 1. Biosimilar Monoclonal Antibody Picture
Figure 2. Global Biosimilar Monoclonal Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Type in 2023
Figure 4. Limited Dilution Method
Figure 5. Micromanipulation
Figure 6. Soft Agar Plate Method
Figure 7. Others
Figure 8. Global Biosimilar Monoclonal Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Biosimilar Monoclonal Antibody Consumption Value Market Share by Application in 2023
Figure 10. Chronic & Autoimmune Diseases Picture
Figure 11. Oncology Picture
Figure 12. Others Picture
Figure 13. Global Biosimilar Monoclonal Antibody Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Biosimilar Monoclonal Antibody Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Biosimilar Monoclonal Antibody Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Region in 2023
Figure 18. North America Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Biosimilar Monoclonal Antibody Revenue Share by Players in 2023
Figure 24. Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Biosimilar Monoclonal Antibody Market Share in 2023
Figure 26. Global Top 6 Players Biosimilar Monoclonal Antibody Market Share in 2023
Figure 27. Global Biosimilar Monoclonal Antibody Consumption Value Share by Type (2019-2024)
Figure 28. Global Biosimilar Monoclonal Antibody Market Share Forecast by Type (2025-2030)
Figure 29. Global Biosimilar Monoclonal Antibody Consumption Value Share by Application (2019-2024)
Figure 30. Global Biosimilar Monoclonal Antibody Market Share Forecast by Application (2025-2030)
Figure 31. North America Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 41. France Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value Market Share by Region (2019-2030)
Figure 48. China Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 51. India Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 65. Biosimilar Monoclonal Antibody Market Drivers
Figure 66. Biosimilar Monoclonal Antibody Market Restraints
Figure 67. Biosimilar Monoclonal Antibody Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibody in 2023
Figure 70. Manufacturing Process Analysis of Biosimilar Monoclonal Antibody
Figure 71. Biosimilar Monoclonal Antibody Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Biosimilar Monoclonal Antibody Picture
Figure 2. Global Biosimilar Monoclonal Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Type in 2023
Figure 4. Limited Dilution Method
Figure 5. Micromanipulation
Figure 6. Soft Agar Plate Method
Figure 7. Others
Figure 8. Global Biosimilar Monoclonal Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Biosimilar Monoclonal Antibody Consumption Value Market Share by Application in 2023
Figure 10. Chronic & Autoimmune Diseases Picture
Figure 11. Oncology Picture
Figure 12. Others Picture
Figure 13. Global Biosimilar Monoclonal Antibody Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Biosimilar Monoclonal Antibody Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Biosimilar Monoclonal Antibody Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Biosimilar Monoclonal Antibody Consumption Value Market Share by Region in 2023
Figure 18. North America Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Biosimilar Monoclonal Antibody Revenue Share by Players in 2023
Figure 24. Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Biosimilar Monoclonal Antibody Market Share in 2023
Figure 26. Global Top 6 Players Biosimilar Monoclonal Antibody Market Share in 2023
Figure 27. Global Biosimilar Monoclonal Antibody Consumption Value Share by Type (2019-2024)
Figure 28. Global Biosimilar Monoclonal Antibody Market Share Forecast by Type (2025-2030)
Figure 29. Global Biosimilar Monoclonal Antibody Consumption Value Share by Application (2019-2024)
Figure 30. Global Biosimilar Monoclonal Antibody Market Share Forecast by Application (2025-2030)
Figure 31. North America Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 41. France Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Biosimilar Monoclonal Antibody Consumption Value Market Share by Region (2019-2030)
Figure 48. China Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 51. India Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Biosimilar Monoclonal Antibody Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Biosimilar Monoclonal Antibody Consumption Value (2019-2030) & (USD Million)
Figure 65. Biosimilar Monoclonal Antibody Market Drivers
Figure 66. Biosimilar Monoclonal Antibody Market Restraints
Figure 67. Biosimilar Monoclonal Antibody Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibody in 2023
Figure 70. Manufacturing Process Analysis of Biosimilar Monoclonal Antibody
Figure 71. Biosimilar Monoclonal Antibody Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
